- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma in Korea, Democratic People's Republic of
Total 13 results
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Follicular Lymphoma or Mantle Cell LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedRelapsed or Refractory Peripheral T-cell LymphomaKorea, Republic of
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Marginal Zone B-cell LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedRelapsed and/or Refractory Cutaneous T-cell LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedRelapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin LymphomaKorea, Republic of
-
Samsung Medical CenterRecruitingRelapsed and/or Refractory Non-Hodgkin T-cell LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedPrimary Mediastinal Large B-cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaKorea, Republic of
-
Kura Oncology, Inc.CompletedRelapsed or Refractory Peripheral T-Cell LymphomaUnited States, Spain, Korea, Republic of
-
AstraZenecaParexelActive, not recruitingRelapsed or Refractory B-cell Non-Hodgkin LymphomaUnited States, Korea, Republic of, Canada, United Kingdom, Spain, France, Denmark
-
Dizal PharmaceuticalsCompletedRelapsed or Refractory Peripheral T Cell LymphomaKorea, Republic of, United States, China, Australia
-
Merck Sharp & Dohme LLCActive, not recruitingRelapsed or Refractory Diffuse Large B-Cell LymphomaUnited States, China, Poland, Israel, Canada, Chile, Czechia, Estonia, France, Greece, Italy, Korea, Republic of, Norway, Spain, Sweden, Thailand, Turkey
-
GenmabRecruitingAcute Myeloid Leukemia (AML) | Diffuse Large B Cell Lymphoma (DLBCL) | Relapsed or Refractory Multiple Myeloma (RRMM)United States, Korea, Republic of, Netherlands, Denmark, Australia, New Zealand, Poland, Spain, Sweden, Czechia, Malaysia, Greece, Moldova, Republic of, Georgia, Ukraine, France, Hungary, North Macedonia, Bosnia and Herzegovina